What Is The Most Accurate Test For Kidney Function?

Kidney function is not measured by a single perfect test. Instead, doctors use a combination of blood and urine tests to build a complete picture. The most accurate way to assess overall kidney function is the estimated glomerular filtration rate, or eGFR, which is calculated from a blood test measuring creatinine. This number tells you what percentage of your kidney function remains and is the standard used by doctors worldwide to diagnose and stage chronic kidney disease.

Why eGFR Is the Gold Standard for Measuring Kidney Function

The glomerular filtration rate (GFR) is the amount of blood your kidneys filter every minute. It is the single best measure of how well your kidneys are working. You cannot measure GFR directly without a complex procedure, so doctors use a calculation based on a blood test.

This calculation is called eGFR, with the “e” standing for estimated. The formula uses your blood creatinine level along with your age, sex, and sometimes race. The result is a number that represents your kidney function as a percentage. A normal eGFR is 90 or above. An eGFR below 60 for three months or longer indicates chronic kidney disease.

The eGFR test is accurate because creatinine is a waste product produced by muscle at a steady rate. Healthy kidneys filter it out of the blood completely. When kidney function declines, creatinine builds up in the blood. The eGFR formula translates that creatinine level into a meaningful measure of filtration capacity.

No other single test gives you this direct picture of how well the kidneys are filtering waste. This is why the eGFR is considered the most accurate starting point for evaluating kidney function.

How the eGFR Blood Test Works

The eGFR test begins with a simple blood draw. The lab measures your serum creatinine, which is the amount of creatinine in your blood. The result is then plugged into a formula that accounts for variables that naturally affect creatinine levels.

Age matters because muscle mass tends to decrease as people get older. Sex matters because men generally have more muscle mass than women. Both factors change what a “normal” creatinine level looks like for any given person.

The most commonly used formula in the United States is called the CKD-EPI equation. It was developed to provide more accurate estimates, especially for people with normal or mildly reduced kidney function. Older formulas like the MDRD equation are still used in some labs but are less accurate at higher GFR levels.

One important limitation of eGFR is that it is an estimate, not a direct measurement. The result can vary slightly from day to day. Dehydration, a high-protein meal, or intense exercise before the blood draw can temporarily raise creatinine and lower your eGFR reading. For this reason, doctors repeat the test to confirm results before making a diagnosis.

What the Urine Albumin Test Adds to the Picture

While eGFR measures how much blood the kidneys filter, it does not tell you about kidney damage. This is where the urine albumin test comes in. Albumin is a protein that normally stays in the blood. When the kidneys are damaged, albumin leaks into the urine.

The test measures the amount of albumin in your urine relative to creatinine. This is called the urine albumin-to-creatinine ratio, or UACR. A normal UACR is below 30 milligrams per gram. A UACR between 30 and 300 indicates early kidney damage. A UACR above 300 indicates more significant damage.

This test is critical because kidney damage can occur while the eGFR is still normal. A person can have an eGFR of 95 and still have albumin in the urine, which signals early kidney disease. Conversely, a person can have a low eGFR with no albumin in the urine, which can happen with certain types of kidney disease.

Doctors use both tests together to diagnose chronic kidney disease. The diagnostic criteria require either an eGFR below 60 for three months or evidence of kidney damage such as albuminuria for three months. Each test catches what the other might miss.

Blood Urea Nitrogen and Its Limited Role

Blood urea nitrogen, or BUN, is another blood test that reflects kidney function. Urea is a waste product created when the liver breaks down protein. The kidneys filter urea out of the blood, so high levels can indicate poor kidney function.

However, BUN is not an accurate standalone test for kidney function. Many factors unrelated to the kidneys can raise BUN levels. Dehydration, a high-protein diet, gastrointestinal bleeding, and certain medications can all elevate BUN even when the kidneys are healthy.

Doctors sometimes use the BUN-to-creatinine ratio to help determine the cause of kidney problems. A high ratio can suggest dehydration or reduced blood flow to the kidneys. A normal ratio with elevated creatinine points more directly to kidney disease itself.

BUN is useful information, but it is not the most accurate test. It is always interpreted alongside creatinine and eGFR, never alone.

Why Cystatin C May Be More Accurate in Some Cases

Cystatin C is a protein produced by all cells in the body at a constant rate. Like creatinine, it is filtered by the kidneys. Unlike creatinine, cystatin C is not affected by muscle mass. This makes it potentially more accurate in people with very low or very high muscle mass.

Some research suggests that an eGFR calculated using cystatin C is more accurate than one based on creatinine alone. This is particularly true for older adults, people with frailty, and those with unusual body composition. The cystatin C-based eGFR can also help confirm a diagnosis when creatinine-based results are borderline.

However, cystatin C testing is more expensive and not universally available. It is also affected by thyroid disease and corticosteroid use, which can limit its accuracy in some patients. Most guidelines recommend cystatin C as a confirmatory test rather than a first-line screening tool.

For most people, the standard creatinine-based eGFR is sufficient and accurate. Cystatin C is reserved for cases where the creatinine-based estimate may be misleading.

When a Direct GFR Measurement Is Needed

There are situations where even eGFR is not accurate enough. In these cases, doctors may order a direct measurement of GFR using a substance called iohexol or inulin. This is called a measured GFR or mGFR.

The test involves injecting a substance that is filtered entirely by the kidneys and measuring how quickly it disappears from the blood. This provides a true measurement of filtration rate rather than an estimate. It is the most accurate test for kidney function that exists.

mGFR testing is rarely used in routine practice. It is time-consuming, requires multiple blood draws, and is more expensive than standard testing. It is reserved for specific situations such as evaluating living kidney donors, monitoring chemotherapy drug dosing, or confirming results when eGFR and other tests disagree significantly.

For the vast majority of people, the eGFR provides enough accuracy for diagnosis and treatment decisions. Direct measurement is a specialized tool for complex cases.

How Often Should You Get Tested

Testing frequency depends on your risk factors and current kidney function. People with diabetes, high blood pressure, or a family history of kidney disease should have kidney function tests at least once a year. People with known chronic kidney disease may need testing every three to six months depending on the stage.

If you have no risk factors and a normal eGFR, routine screening every one to two years is reasonable as part of an annual physical. Your doctor will determine the right interval based on your individual health profile.

Early detection matters because chronic kidney disease often has no symptoms until significant function is lost. Many people do not know they have kidney disease until an eGFR test reveals it. By the time symptoms appear, kidney function may already be below 30 percent.

A simple blood test and urine test can catch kidney disease early, when treatment can slow its progression. This is why knowing your eGFR and UACR numbers is more valuable than waiting for symptoms to develop.